| Literature DB >> 32552706 |
Christine Friedrich1, Mohamed Ahmed Salem2, Thomas Puehler2, Grischa Hoffmann2, Georg Lutter2, Jochen Cremer2, Assad Haneya2.
Abstract
BACKGROUND: Although gender-related disparities in cardiovascular surgery have been investigated extensively in the past decades, knowledge about the impact of gender on outcomes after surgery for acute aortic dissection type A (AADA) is sparse. This study investigated the impact of gender on early morbidity and mortality and follow-up outcome in patients after surgery for AADA and to analyze gender-related risk factors for 30-day mortality.Entities:
Keywords: Aorta; Dissection; Gender; Risk factors; Survival
Mesh:
Year: 2020 PMID: 32552706 PMCID: PMC7301454 DOI: 10.1186/s13019-020-01189-w
Source DB: PubMed Journal: J Cardiothorac Surg ISSN: 1749-8090 Impact factor: 1.637
Pre- and intraoperative variables with univariate association to 30-d-mortality (p-values ≤0.10) and interaction between sex and risk factors (logistic regression analysis, p-values)
| Variable | All Patients ( | Male ( | Female ( | Sex-specific Interaction |
|---|---|---|---|---|
| Total cases | 368 | 242 | 126 | |
| Female gender | 0.545 | |||
| Age, years | 0.100 | 0.971 | 0.123 | |
| Logistic EuroSCORE I (%) | 0.599 | |||
| Cardiopulmonary resuscitation 48 h preoperative | 0.226 | |||
| Cardiogenic shock | 0.266 | |||
| Intubated | 0.821 | |||
| Chronic obstructive pulmonary disease | 0.059 | |||
| 0.198 | ||||
| Peripheral arterial disease | 0.083 | |||
| Coronary heart disease | ||||
| Previous percutaneous coronary intervention | ||||
| Previous cardiac surgery | 0.999 | |||
| Diabetes mellitus type II | 0.059 | 0.928 | ||
| Hyperlipoproteinemia | ||||
| Creatinine (μmol/l) preoperativea | 0.051 | 0.334 | ||
| Chronic renal insufficiency | ||||
| 0.434 | ||||
| Length of surgery (min) | 0.060 | 0.231 | ||
| Cardiopulmonary bypass time (min) | 0.855 | |||
| Surgical procedure | ||||
| Additional coronary artery bypass graft | 0.508 | |||
| 0.232 | ||||
| 0.998 | ||||
| Number of RBC, (U) | 0.658 | |||
| Number of platelets, (U) | 0.198 | |||
TEVAR/EVAR, (thoracic) endovascular aortic repair, RBC Red blood cell concentrate (unit)
a19% missing values; italic text, inverse association; bold text, p-values ≤0.05
Demographic and clinical characteristics of the study population
| Variable | All Patients ( | Male ( | Female ( | |
|---|---|---|---|---|
| Age, years | 62.8 ± 12.4 63.7 (54.2;72.5) | 60.4 ± 12.0 60.6 (52.2;69.1) | 67.5 ± 11.8 70.7 (60.3;76.4) | |
| Logistic EuroSCORE I | 23.1 (12.2;40.5) | 19.7 (10.2;35.3) | 31.0 (21.0;51.8) | |
| EuroSCORE II | 5.45 (3.06;12.41) | 4.72 (2.75;11.63) | 6.6 (4.0;13.4) | |
| BSA (m2) | 2.0 ± 0.2 | 2.1 ± 0.2 | 1.8 ± 0.2 | |
| Body mass index (kg/m2) | 26.3 (23.9;29.0) | 26.8 (24.5;29.3) | 25.7 (23.1;28.1) | |
| Body mass index > 30 (kg/m2) | 74 (20.2%) | 51 (21.1%) | 23 (18.4%) | 0.545 |
| Arterial hypertension | 262 (73.0%) | 170 (72.6%) | 92 (73.6%) | 0.847 |
| Pulmonary hypertension | 4 (1.1%) | 2 (0.9%) | 2 (1.6%) | 0.613 |
| Type 2 Diabetes mellitus | 21 (6.0%) | 10 (4.4%) | 11 (8.9%) | 0.090 |
| - Insulin dependent | 7 (2.0%) | 4 (1.8%) | 3 (2.4%) | 0.701 |
| Hyperlipoproteinemia | 50 (14.3%) | 34 (15.0%) | 16 (13.0%) | 0.604 |
| COPD | 22 (6.2%) | 12 (5.2%) | 10 (8.0%) | 0.289 |
| Peripheral arterial disease | 16 (4.5%) | 9 (3.9%) | 7 (5.6%) | 0.454 |
| Current Smoking* | 71 (23.4%) | 56 (27.6%) | 15 (16.0%) | |
| Atrial fibrillation | 51 (13.9%) | 32 (13.3%) | 19 (15.1%) | 0.636 |
| Marfan syndrome | 9 (2.5%) | 7 (3.0%) | 2 (1.6%) | 0.504 |
| Bicuspid aortic valve | 9 (2.4%) | 8 (3.3%) | 1 (0.8%) | 0.174 |
| Neurological deficits | 73 (20.3%) | 45 (19.3%) | 28 (22.2%) | 0.513 |
| DeBakey type I** | 259 (78.5%) | 181 (81.5%) | 78 (72.2%) | 0.053 |
| DeBakey type II** | 71 (21.5%) | 41 (18.5%) | 30 (27.8%) | 0.053 |
| Creatinine (μmol/l)*** | 88.8 (72.2;114.0) | 98.1 (80.0;120.5) | 80.0 (63.8;95.3) | |
| Chronic renal insufficiency | 48 (13.6%) | 36 (15.7%) | 12 (9.8%) | 0.120 |
| Renal replacement therapy | 7 (2.0%) | 4 (1.7%) | 3 (2.4%) | 0.700 |
| Coronary heart disease | 63 (18.0%) | 39 (17.3%) | 24 (19.4%) | 0.625 |
| Previous PCI | 24 (6.8%) | 15 (6.5%) | 9 (7.2%) | 0.808 |
| Previous cardiac surgery | 12 (3.4%) | 9 (3.9%) | 3 (2.4%) | 0.552 |
| IABP/ECLS | 5 (1.4%) | 5 (2.1%) | 0 (0.0%) | 0.170 |
| Aortic valve stenosis**** | 10 (2.9%) | 4 (1.8%) | 6 (5.1%) | 0.097 |
| Aortic valve insufficiency**** | 137 (40.1%) | 86 (38.2%) | 51 (43.6%) | 0.337 |
| Acute myocardial infarction | 14 (3.8%) | 8 (3.4%) | 6 (4.8%) | 0.570 |
| Cardiogenic shock | 27 (7.4%) | 17 (7.2%) | 10 (7.9%) | 0.792 |
| CPR (≤ 48 h) | 31 (8.5%) | 20 (8.4%) | 11 (8.7%) | 0.915 |
| Intubated at admission | 39 (10.7%) | 25 (10.5%) | 14 (11.2%) | 0.828 |
| Coronary angiography | 130 (36.5%) | 81 (34.9%) | 49 (39.5%) | 0.390 |
Magnetic resonance Imaging | 9 (2.5%) | 6 (2.6%) | 3 (2.4%) | 1.000 |
BSA Body surface area, COPD Chronic obstructive pulmonary disease, PCI Percutaneous coronary intervention, IABP Intra-aortic balloon pump, ECLS Extracorporeal life support, CPR Cardiopulmonary resuscitation; *18% missing values, **10% missing values; ***19% missing values, ****7% missing values; bold text, p-values ≤0.05; italic text, subheadings
Operative data
| Variable | All Patients ( | Male ( | Female ( | |
|---|---|---|---|---|
| Length of surgery (min) | 280 (227;345) | 287 (235;356) | 254 (214;317) | |
| Cardiopulmonary bypass time (min) | 166 (135;212) | 171 (139;220) | 149 (124;196) | |
| Cross-clamp time (min) | 89 (70;127) | 94 (72; 135) | 85 (64;114) | |
| Circulatory arrest (min) | 33 (26;46) | 35 (26;51) | 30 (25;40) | |
| Number of packed red blood cells (unit) * | 4 (0–20) | 2 (0–20) | 4 (0–20) | |
| Number of fresh frozen plasma (unit)* | 0 (0–21) | 0 (0–21) | 2 (0–17) | 0.500 |
| Number of platelets (unit)* | 2 (0–5) | 2 (0–5) | 2 (0–5) | 0.168 |
| Isolated supracoronary replacement | 186 (50.5%) | 108 (44.6%) | 78 (61.9%) | |
| Partial arch replacement | 78 (21.2%) | 55 (22.7%) | 23 (18.3%) | 0.319 |
| Total arch replacement | 48 (13.0%) | 37 (15.3%) | 11 (8.7%) | 0.076 |
| - Elephant-trunk | 7 (1.9%) | 7 (2.9%) | 0 (0.0%) | 0.101 |
| Conduit / Bentall operation | 63 (17.1%) | 44 (18.2%) | 19 (15.1%) | 0.453 |
| David operation | 22 (6.0%) | 20 (8.3%) | 2 (1.6%) | |
| Additional AVR | 57 (15.5%) | 42 (17.4%) | 15 (11.9%) | 0.165 |
| Additional CABG | 35 (9.6%) | 19 (8.0%) | 16 (12.7%) | 0.147 |
| Diameter of ascending aorta prostheses (mm) | 28 (28;30) | 28 (28;30) | 28 (26;30) | 0.677 |
| Additional MVR | 1 (0.3%) | 1 (0.4%) | 0 (0.0%) | 1.000 |
| TEVAR/EVAR | 23 (6.3%) | 19 (7.9%) | 4 (3.2%) | 0.077 |
| Femoral artery | 78 (21.2%) | 46 (19.0%) | 32 (25.4%) | 0.155 |
| Ascending aorta | 102 (27.7%) | 67 (27.7%) | 35 (27.8%) | 0.985 |
| Aortic arch | 14 (3.8%) | 9 (3.7%) | 5 (4.0%) | 1.000 |
| Subclavian artery | 1 (0.3%) | 1 (0.4%) | 0 (0.0%) | 1.000 |
| Apex | 5 (1.4%) | 4 (1.7%) | 1 (0.8%) | 0.664 |
| Pulmonary vein | 168 (45.7%) | 115 (47.5%) | 53 (42.1%) | 0.319 |
| Right atrium | 330 (59.9%) | 212 (95.1%) | 118 (97.5%) | 0.394 |
| Bicaval | 4 (1.2%) | 4 (1.8%) | 0 (0.0%) | 0.302 |
| Femoral vein | 10 (2.9%) | 7 (3.1%) | 3 (2.5%) | 1.000 |
| Hemofiltration *** | 83 (26.8%) | 47 (23.0%) | 36 (34.0%) | |
AVR Aortic valve replacement, MVR Mitral valve reconstruction / replacement, CABG Coronary artery bypass graft, TEVAR Thoracic endovascular aortic repair, EVAR Endovascular aortic repair; * 9–10% missing values, **6.5% missing values ***16% missing values; bold text, p-values ≤0.05; italic text, subheadings
Postoperative data and outcomes
| Variable | All Patients ( | Male ( | Female ( | |
|---|---|---|---|---|
| 48 h-drainage loss (ml)* | 850 (500;1300) | 885 (500;1458) | 750 (350;1150) | |
| Postoperative blood transfusion | 247 (70.8%) | 166 (72.2%) | 81 (68.1%) | 0.424 |
| Total number of packed red blood cells, unit | 3 (0–56) | 3.5 (0–56) | 2 (0–21) | |
| Total number of fresh frozen plasma, unit | 0 (0–76) | 0 (0–76) | 0 (0–25) | |
| Total number of platelets, unit | 0 (0–20) | 0 (0–20) | 0 (0–7) | |
| IABP/ECLS | 10 (2.8%) | 8 (3.4%) | 2 (1.7%) | 0.504 |
| Reintubation | 66 (18.0%) | 51 (21.2%) | 15 (11.9%) | |
| Tracheotomy | 84 (22.9%) | 63 (26.1%) | 21 (16.7%) | |
| Postoperative delirium | 69 (18.9%) | 57 (23.8%) | 12 (9.5%) | |
| Postoperative myocardial infarction | 4 (1.1%) | 3 (1.3%) | 1 (0.8%) | 1.000 |
| TIA / Stroke | 56 (15.3%) | 40 (16.7%) | 16 (12.7%) | 0.316 |
| Electrical cardioversion | 26 (7.1%) | 14 (5.8%) | 12 (9.5%) | 0.192 |
| CPR | 28 (7.7%) | 16 (6.7%) | 12 (9.5%) | 0.334 |
| Bronchopulmonary infection | 48 (13.1%) | 38 (15.8%) | 10 (7.9%) | |
| Bacteriaemia/sepsis | 17 (4.6%) | 10 (4.2%) | 7 (5.6%) | 0.549 |
| Rethoracotomy | 62 (16.9%) | 45 (18.7%) | 17 (13.5%) | 0.209 |
| Sternal wound infection/VAC revision | 6 (1.6%) | 6 (2.5%) | 0 (0.0%) | 0.097 |
| AKI KDIGO | 80 (22.0%) | 52 (21.8%) | 28 (22.6%) | 0.858 |
| New–onset of Hemodialysis | 78 (21.4%) | 51 (21.2%) | 27 (21.8%) | 0.892 |
| Temporary dialysis (d) | 4 (2;12) | 6 (3;13.5) | 3 (1;5) | |
| Atrial fibrillation | 40 (11.4%) | 26 (11.1%) | 14 (11.9%) | 0.833 |
| Ventilation time (h) | 64 (21;188) | 63 (21;237) | 67 (19;145) | 0.270 |
| ICU time (d) | 5 (2;11) | 5 (2;12) | 5 (2;9) | 0.442 |
| Postoperative days | 11 (7;19) | 11.5 (8;20) | 9.5 (7;17) | 0.090 |
| Hospital Mortality | 61 (17.0%) | 38 (16.2%) | 23 (18.4%) | 0.604 |
| Cardiac death | 36 (56.3%) | 22 (55.0%) | 14 (58.3%) | |
| Cerebral death | 4 (6.3%) | 2 (5.0%) | 2 (8.3%) | |
| Sepsis | 3 (4.7%) | 3 (7.5%) | 0 (0.0%) | |
| MOF | 21 (32.8%) | 13 (32.5%) | 8 (33.3%) | |
| 30 d-mortality | 64 (17.4%) | 40 (16.5%) | 24 (19.0%) | 0.545 |
IABP Intra-aortic balloon pump, ECLS Extracorporeal life support, TIA Transient ischemic attack, CPR Cardiopulmonary resuscitation, AKI Acute kidney injury, KDIGO Kidney Disease: Improving Global Outcomes, MOF Multiple organ failure, * 8.2% missing values; bold text, p-values ≤0.05
Fig. 1Kaplan-Meier survival curve of women and men after surgical repair of AADA
Fig. 2Kaplan-Meier survival curve of women and men aged younger than 70 years after surgical repair of AADA
Fig. 3Kaplan-Meier survival curve of women and men aged 70 years or older after surgical repair of AADA
Allover and sex-specific adjusted pre- and intraoperative risk factors for 30-day-mortality (variables with significant or nearly significant p-values presented)
| Variable | Total | Male | Female | ||||||
|---|---|---|---|---|---|---|---|---|---|
| OR | CI | p-value | OR | CI | p-value | OR | CI | ||
| Age (years) | 0.058 | 1.038 | 0.999–1.079 | ||||||
| DM 2 | 0.052 | 3.368 | 0.988–11.479 | ||||||
| COPD | 9.255 | 1.579–54.234 | |||||||
| PAD | 7.274 | 1.065–49.682 | |||||||
| Intubated | 7.499 | 1.840–30.565 | |||||||
| CPR | 12.861 | 4.627–35.746 | 13.379 | 4.051–44.190 | |||||
| CPB | 1.008 | 1.002–1.014 | 1.009 | 1.003–1.015 | |||||
| RBC | 1.130 | 1.036–1.233 | 1.110 | 1.002–1.229 | 1.187 | 1.028–1.371 | |||
| CABG | 3.350 | 1.201–9.346 |
OR Odds Ratio, CI Confidence interval, DM 2 Diabetes mellitus type 2, COPD Chronic obstructive pulmonary disease, PAD Peripheral arterial disease, CPR Cardiopulmonary resuscitation (≤ 48 h preoperative), CPB Cardiopulmonary bypass time (min), RBC Number of red blood cell concentrates (unit) intraoperative, CABG Additional CABG surgery; bold text, p-values ≤0.05
Allover and sex-specific adjusted preoperative risk factors for 30-day-mortality (variables with significant or nearly significant p-values presented)
| Variable | Total | Male | Female | ||||||
|---|---|---|---|---|---|---|---|---|---|
| OR | CI | p-value | OR | CI | OR | CI | |||
| Age (years) | 1.082 | 1.013–1.155 | |||||||
| DM 2 | 0.052 | 2.847 | 0.990–8.188 | ||||||
| Hyperlipoproteinemia | 6.786 | 1.611–28.596 | |||||||
| Coronary heart disease | 2.568 | 1.246–5.292 | 5.834 | 1.779–19.135 | |||||
| CPR | < | 12.272 | 5.194–28.996 | 16.727 | 5.834–47.954 | 6.973 | 1.297–37.500 |
OR Odds Ratio, CI Confidence interval, DM 2 Diabetes mellitus type 2, CPR Cardiopulmonary resuscitation (≤ 48 h preoperative); bold text, p-values ≤0.05
Fig. 4Visual representation of main findings